Literature DB >> 2394739

Pulmonary fibroblasts: an in vitro model of emphysema. Regulation of elastin gene expression.

J A Foster1, C B Rich, M F Miller.   

Abstract

Disruption and degradation of interstitial elastic fibers are significant characteristics of pulmonary emphysema. In order to examine the responses of elastogenic cells to the conditions mimicking degradation of interstitial pulmonary elastin, rat pulmonary fibroblast cultures were used as an in vitro model. Second passage fibroblasts were divided into two different environmental situations to represent cells adjacent to and remote from the site of elastase-digested matrix. One set of cell cultures was briefly digested with pancreatic elastase. The resultant digest was then added back incrementally to the medium of elastase-digested cell cultures and to the medium of a second set of undigested cultures. Both sets of cell cultures remained viable and metabolically active during these treatments (96 h of incubation) as judged by protein synthesis, cell number, and steady-state levels of beta-actin mRNA. However, the two sets of cultures exhibited opposite responses in elastin gene expression with addition of increasing amounts of the elastase digest. The elastase-digested cultures exhibited a 200% increase in extractable soluble elastin and a 186% increase in tropoelastin mRNA with the addition of increasing amounts of the elastase digest to the medium. Conversely, the amount of soluble elastin recovered from the undigested cultures decreased 75%, and the steady-state level of tropoelastin mRNA decreased 63%. Soluble elastin peptides generated from oxalic acid treatment of purified elastin were shown to decrease tropoelastin mRNA in undigested cell cultures in the same manner as the elastase digest. Based on these data, we propose that pulmonary fibroblast elastin gene expression can be controlled coordinately by the state of the extracellular matrix and solubilized peptides derived from that matrix. Such integrated regulation may serve to localize elastin repair mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394739

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  A computational approach for deciphering the organization of glycosaminoglycans.

Authors:  Jean L Spencer; Joel A Bernanke; Jo Ann Buczek-Thomas; Matthew A Nugent
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

2.  Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis.

Authors:  Scott L Schissel; Sarah E Dunsmore; Xiaoli Liu; Robert W Shine; Mark A Perrella; Matthew D Layne
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

3.  Inhibition of histone acetyltransferase by glycosaminoglycans.

Authors:  Jo Ann Buczek-Thomas; Edward Hsia; Celeste B Rich; Judith A Foster; Matthew A Nugent
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

4.  Collagen breakdown products and lung collagen metabolism: an in vitro study on fibroblast cultures.

Authors:  C Gardi; P Calzoni; P Marcolongo; E Cavarra; L Vanni; G Lungarella
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

5.  Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity.

Authors:  Elma Kurtagic; Mark P Jedrychowski; Matthew A Nugent
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-09       Impact factor: 5.464

Review 6.  Mesenchymal cell fate and phenotypes in the pathogenesis of emphysema.

Authors:  Jeffrey C Horowitz; Fernando J Martinez; Victor J Thannickal
Journal:  COPD       Date:  2009-06       Impact factor: 2.409

7.  Ascorbate enhances elastin synthesis in 3D tissue-engineered pulmonary fibroblasts constructs.

Authors:  Kelsey E Derricks; Celeste B Rich; Jo Ann Buczek-Thomas; Matthew A Nugent
Journal:  Tissue Cell       Date:  2013-05-03       Impact factor: 2.466

8.  Speleotherapy - modern bio-medical perspectives.

Authors:  H Lăzărescu; I Simionca; M Hoteteu; L Mirescu
Journal:  J Med Life       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.